A significant upregulation of protein levels of Notch1 and Notch2 receptors (Figure 7E), and Hes1 and Hey1 products (Figure 7F) was observed in bortezomib-treated group when compared with tumor alone group. This evidence concerns the gene HES1 and neoplasm.